Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitronesin injection in acute ischemic stroke (Phase II)
CTR20190094Phase 2Completed
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitronesin in ischemic stroke, sponsored by Guangzhou Magpie Pharmaceutical. Started Apr 2019; status: completed.
02
Drugs
nitronesin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20190094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190094.